Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
It’s Tough to Stop Sex, Study of U.S. AIDS Effort Shows

Researchers have found no benefits from a decade-long attempt to curb the spread of HIV in Africa by promoting abstinence and monogamy. The U.S. has spent more than $1.4 billion since 2004 telling young people in Africa to abstain from sex before marriage and then commit to a single partner. That funding didn’t influence the number of sex partners people had, the age at which they started having sex, or teen pregnancy rates, according to a study published on Monday. See http://www.aidsmap.com/page/2949285/

Published
3 hours ago
From
Bloomberg
A simple ask in 2016: the UN goal of universal HIV treatment

Last week, the working draft for 2016 UN Political Declaration on HIV/AIDS was released with only a few days for comments. Called the Zero draft, like previous statements produced every five years, it is a list of observations, comments and goals. But using the UN Statement as a platform of human rights has become disconnected from the scientific and medical advances in HIV over the last five years. The bulk of the draft document could have been written at any time during the epidemic, certainly most of it could have been written in 2011. There is only one reference to dramatic changes in the WHO 2015 guidelines and only two references to PrEP.

Published
28 April 2016
From
i-Base
Namibia: Over 144 000 On ARV Treatment

Close to 144 000 people are on antiretroviral (ARV) treatment countrywide, according to the latest statistics released by the Ministry of Health and Social Services.

Published
26 April 2016
From
AllAfrica
New York Insurers to Change Coverage of Hepatitis C Drugs

Seven health-insurance companies in New York will change their criteria for covering costly drugs that cure chronic hepatitis C under the terms of agreements with the office of State Attorney General Eric Schneiderman.

Published
26 April 2016
From
Wall Street Journal
ViiV Healthcare, Medicines Patent Pool Extend Licence for Dolutegravir to All Lower Middle-Income Countries

The Medicines Patent Pool (MPP) and ViiV Healthcare announced an extension of their current licensing agreement today to increase access to dolutegravir (DTG), a promising new antiretroviral, to cover all remaining lower middle-income countries. The amendment to the 2014 licence specifically allows generic medicine distribution in four countries with patents - Armenia, Moldova, Morocco and Ukraine - that were not covered in the initial agreement. MPP sub-licensees can now sell in countries that are home to 94% of people living with HIV in the developing world.

Published
25 April 2016
From
ViiV Healthcare press release
This Pill Prevents HIV—But It's Treated Like An Illicit Drug

Around the world, people have to jump through hoops, and sometimes break laws, just to get it.

Published
23 April 2016
From
Vocativ
How Can We Help Young People Under Age 18 Get PrEP?

Getting PrEP into the hands of young people at high risk for HIV infection is a priority that experts are now discussing. A recent webinar and Q&A session hosted by HIVE brought together PrEP providers from across the country to talk about some of these issues and share successes and challenges.

Published
22 April 2016
From
BETA blog
Fight against HIV doomed to fail without urgent focus on West and Central Africa

Globally agreed goals to curb the HIV epidemic by 2020 will not be met unless the HIV response is drastically accelerated in West and Central Africa, where people living with HIV continue to suffer needlessly and die silently, Médecins Sans Frontières (MSF) warned in a new report released today.

Published
20 April 2016
From
MSF
Hepatitis C: no more treatment rationing; universal access to generic medicines everywhere!

People with hepatitis C virus (HCV) and their allies from Spain and around the world have gathered at the International Liver Congress to protest the outrageous price of life-saving HCV medicines. They are pushing for generic competition to bring down the price of HCV treatment and ensure universal access.

Published
18 April 2016
From
Treatment Action Group
Low-cost generic hepatitis C drugs match branded products in viral response

Generic versions of direct-acting antivirals purchased from China and India by people unable to obtain treatment in their own countries were just as effective and safe as

Published
16 April 2016
By
Keith Alcorn
← First12345...107Next →

Filter by country